Adherex Technologies Incorporated

Adherex Technologies is a biotechnology company developing novel therapeutics based on cell adhesion technologies. Adherex is currently developing a portfolio of biologically active small molecules based on the cadherin family of cell adhesion molecules. Cadherins are the major biological glues that hold tissues intact. They play an important role in maintaining the integrity of tissues and barriers in the body, development, recovery from injury, and cancer. Adherex has successfully developed compounds that alter the level of adhesion between cells. The Company is now investigating the applications of these cell adhesion modulators.

Adherex has discovered a revolutionary new approach to cancer therapy. Our cadherin modulating drug Exherin has displayed potent anti-vascular activity. At therapeutic concentrations it effectively destroys tumor vessels without harming normal vessels. Though initial examination of Exherin's effects may suggest that they are like those of other anti-angiogenesis agents (which block the process of blood vessel formation), Exherin goes far beyond anything those agents can do. Exherin not only stops growth of new tumor vessels, it destroys existing tumor vessels. Adherex is the first and only company in the world that is focused on the relationship between cell-cell adhesion and cancer.

Contact Details: 600 Peter Morand CrescentSuite 340 Ottawa Ontario K1G 5Z3 Canada Tel: (613) 738-8000 Fax: (613) 738-9060 Email: info@adherex.com WWW: www.adherex.com/

Loading...

Recent Publications by Adherex Technologies Incorporated:
Development and validation of a high-performance liquid chromatographic method for the analysis of budesonide. A simple, rapid, and stability indicating reversed-phase high-performance...	14th March, 2007	Adherex Technologies Inc., Durham, NC 27713, USA.	J Pharm Biomed Anal. 2006 Feb 13;40(2):423-8. Epub 2005 Sep 6. DOI Direct Link

BioNews Results for Adherex Technologies Incorporated:
Adherex Reports Second Quarter 2008 Financial Results	Pharma Live:  Aug 13 2008 1:56PM Matching: adherex technologies
Adherex Reports Second Quarter 2008 Financial Results	NewsBlaze:  Aug 13 2008 1:26PM Matching: adherex technologies
Adherex Reports Second Quarter 2008 Financial Results	Therapeutics Daily:  Aug 13 2008 1:28PM Matching: adherex technologies
Adherex Reports Second Quarter 2008 Financial Results	Yahoo!:  Aug 13 2008 1:47PM Matching: adherex technologies
BioPharm America Unveils Conference Program	Pharmalive.com:  Jul 25 2008 6:45AM Matching: adherex technologies
Promote your company here: BioNewsCast - Press Release Distribution	→View more Adherex Technologies Incorporated news.

Adherex Technologies Incorporated Patents:
US Patent No.	Title
7268115	Peptidomimetic modulators of cell adhesion
6569996	Antibody that specifically binds to the cadherin-5 cell adhesion recognition sequence
6472368	Compounds and methods for modulating adhesion molecule function
6472367	Compounds and methods for modulating OB-cadherin mediated cell adhesion
6433149	Compounds and methods for inhibiting cancer metastasis
→View more Adherex Technologies Incorporated patents.

Adherex Technologies Incorporated (ADH) Financial information Links from Barchart
ADH Quote from from Barchart.com
ADH Chart from from Barchart.com
ADH Profile from from Barchart.com
ADH Opinion from from Barchart.com
→View more Adherex Technologies Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 221 times since April 2007, the link to the organisation's website has been followed 58 times

Search for more companies in Ottawa

Search for more companies in Ontario

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Adherex Technologies Incorporated